m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2024. Verfasst von Qi-Qi Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; School of Pharmacy, Anhui Medic…. Hauptthemen laut MEDLINE: DNA Methylation, Epigenesis, Genetic, Liver Cirrhosis, RNA, Untranslated. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Liver fibrosis is a pathological process caused by a variety of chronic liver diseases. Currently, therapeutic options for liver fibrosis are very limited, highlighting the urgent need to explore new treatment approaches. Epigenetic modifications and epitranscriptomic modifications, as reversible regulatory mechanisms, are involved in the development of liver fibrosis. In recent years, researches in epitranscriptomics and epigenetics have opened new perspectives for understanding the pathogenesis of liver fibrosis. Exploring the epigenetic mechanisms of liver fibrosis may provide valuable insights into the development of new therapies for chronic liver diseases. This review primarily focus on the regulatory mechanisms of N6-methyladenosine (m6A) modification, non-coding RNA, and DNA methylation in organ fibrosis. It discusses the interactions between m6A modification and DNA methylation, as well as between m6A modification and non-coding RNA, providing a reference for understanding the interplay between epitranscriptomics and epigenetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; School of Pharmacy, Anhui Medical University, Hefei 230032, China.
- Department of General Surgery, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou 215153, China.
- Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China. Electronic address: taohui@ahmu.edu.cn.
- First Affiliated Hospital, Anhui University of Science & Technology, Huainan 232001, China. Electronic address: chaolu@aust.edu.cn.
- Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China. Electronic address: yangjingjing@ahmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dong, Q. Q., Yang, Y., Tao, H., Lu, C., & Yang, J. J. (2024). m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111302
Vancouver
Dong QQ, Yang Y, Tao H, Lu C, Yang JJ. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111302
BibTeX
@article{Dong2024,
author = {Dong, Qi-Qi and Yang, Yang and Tao, Hui and Lu, Chao and Yang, Jing-Jing},
title = {m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111302}
}
EUVIMED